A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: heave (2), gag (20)

What to expect in the last days and weeks of life: When your loved one is staying in hospital - patient information

Description
This booklet provides information for family, friends and carers who will be supporting a loved one in hospital during their last
Url
/Media/UHS-website-2019/Patientinformation/Bereavement-and-end-of-life/What-to-expect-in-the-last-days-and-weeks-of-life-When-your-loved-one-is-staying-in-hospital-3684-PIL.pdf

Azacitidine Oral

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA -AZACITADINE (ORAL) Regimen • AML – AZACITADINE (ORAL) Indication Oral azacitidine as maintenance therapy in newly diagnosed AML
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine-Oral.pdf

Stress-dose steroid treatment following zoledronic acid infusion - patient information

Description
This factsheet has been written to provide you with important information following your child's treatment with zoledronic acid.
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Stress-dose-steroid-treatment-following-zoledronic-acid-infusion-3003-PIL.pdf

Erdafitinib

Description
Regimen • Urothelial - Erdafitinib Chemotherapy Protocol UROTHELIAL CANCER ERDAFITINIB Indication • Monotherapy treatment of unresectable or metastatic urothelial cancer harbouring a susceptible fibroblast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Erdafitinib.pdf

Brexucel - Cyclophosphamide (900) - Fludarabine (25)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY ALL – BREXUCEL – CYCLOPHOSPHAMIDE (900) – FLUDARABINE (25) This regimen will only be
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Brexucel-Cyclophosphamide-900-Fludarabine-25.pdf

Brigatinib

Description
Chemotherapy Protocol Lung Cancer Regimen Brigatinib • NSCLC – Brigatinib Indication • Brigatinib is indicated as monotherapy for the treatment of adult patients with
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Brigatinib.pdf

AmB-LISOCEL-Cyclophosphamide (300)-Fludarabine (30)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY AmB – LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) Ambulatory Regimen This regimen is
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LISOCEL-Cyclophosphamide-300-Fludarabine-30.pdf

Lisocel – Cyclophosphamide (300) – Fludarabine (30) Ver1

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) This regimen will only be available
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lisocel-–-Cyclophosphamide-300-–-Fludarabine-30.pdf

Gastroscopy with radiofrequency ablation (RFA) aftercare advice - patient information

Description
This factsheet explains what to expect after having a gastroscopy with radiofrequency ablation (RFA).
Url
/Media/UHS-website-2019/Patientinformation/Endoscopy/Gastroscopy-with-radiofrequency-ablation-RFA-aftercare-advice-2256-PIL.pdf

Diarrhoea - patient information

Description
Patient information factsheet Diarrhoea Diarrhoea is passing looser or more frequent stools than is normal for you. It affects most people
Url
/Media/UHS-website-2019/Patientinformation/Generalmedicine/Diarrhoea-1360-PIL.pdf
31 to 40 of 344
Previous … 2 3 4 5 6 … Next